The 2-Minute Rule for conolidine
Andy Chevigné and his group, RTI-5152-12 is postulated to enhance the amounts of opioid peptides that bind to classical opioid receptors within the Mind, resulting in heightened painkilling activity. The LIH-RTI investigate teams established a collaboration settlement and filed a joint patent software in December 2020.Conolidine CONOCB2™, which